RT Journal Article
SR Electronic
T1 613 A phase II study of nivolumab in patients with genetic alterations in DNA damage repair and response who progressed after standard treatment for metastatic solid cancers (KM-06)
JF Journal for ImmunoTherapy of Cancer
JO J Immunother Cancer
FD BMJ Publishing Group Ltd
SP A698
OP A698
DO 10.1136/jitc-2023-SITC2023.0613
VO 11
IS Suppl 1
A1 Kim, Ju Won
A1 Lee, Hyo Jin
A1 Lee, Ji Yoon
A1 Sa, Jason K
A1 Park, Sook Ryun
A1 Kim, Yu
A1 Hwang, In Gyu
A1 Bae, Woo Kyun
A1 Byun, Jae Ho
A1 Kim, Jung Sun
A1 Kang, Eun Joo
A1 Lee, Jeeyun
A1 Shin, Sang
A1 Park, Kyong Hwa
YR 2023
UL http://jitc.bmj.com/content/11/Suppl_1/A698.abstract
AB Markup server — Error Not Found The page you were trying to reach could not be found. Please check the address for the page you were trying to reach. If you believe you have reached this page in error, you may contact us with any questions.